Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $84,107.81 +0.51%
Ethereum $2,680.60 +0.07%
BNB $770.63 -0.17%
Optimism $0.14 -0.10%
Arbitrum $0.22 -0.80%
Solana $120.73 -0.37%
Polygon $0.22 +2.77%
Cosmos $1.84 +3.62%
Avalanche $10.69 +2.41%

Bitcoin $84,107.81 +0.51%
Ethereum $2,680.60 +0.07%
BNB $770.63 -0.17%
Optimism $0.14 -0.10%
Arbitrum $0.22 -0.80%
Solana $120.73 -0.37%
Polygon $0.22 +2.77%
Cosmos $1.84 +3.62%
Avalanche $10.69 +2.41%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed